PLUS1
41.12
-0.105 (-0.25%)
-0.105 (-0.25%)
Upgrade to Real-Time
Market Open
Best deals to access real time data! |
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | RHHBY | OTCMarkets | Depository Receipt |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.105 | -0.25% | 41.12 | 12:36:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 41.07 | 41.05 | 41.27 | 41.225 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 41.12 | 41.13 | 0.01 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume |
|---|---|---|---|---|
| 1,251 | 565,420 | 41.1488 | 23,266,348 | 1,083,562 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:36:08 | 100 | 41.12 | USD |
Roche (QX) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 35.51B | 862.56M | 862.39M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 471.04k | - | 0.00% | - | - |
News Roche (QX)
| Date | Time | Source | Heading |
|---|---|---|---|
| 11/17/2020 | 17:38 | Dow Jones News | Companies Battle Cybersecurity Risks of Having More Remote.. |
| 11/13/2020 | 10:43 | Dow Jones News | Halozyme Therapeutics Sees CHMP Approval for Phesgo |
| 10/21/2020 | 13:50 | Dow Jones News | Prothena Shares Rise 7% on Prasinezumab Study With Roche |
| 10/21/2020 | 09:36 | Dow Jones News | PTC Therapeutics Says Evrysdi Approved in Brazil, Japan NDA.. |
| 10/15/2020 | 05:25 | Dow Jones News | Roche Shares Trade Lower After Sales Decline |
| 10/15/2020 | 02:11 | Dow Jones News | Roche Confirms 2020 Outlook Despite Decrease in Sales |
| 10/13/2020 | 01:50 | Dow Jones News | Roche to Launch Coronavirus Antigen Test |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
RHHBY Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). |
